Ongoing Lung Decline With Age Intensified Response

NCT07676435 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Age-Related Lung Function Decline

Interventions

DRUG: Fisetin
DRUG: Placebo

Sponsor

Cedars-Sinai Medical Center